Analyst Ratings for Biogen (BIIB)
BIIB Rating Summary
BIIB Price Target Summary
- Highest: $398.00 (Goldman Sachs)
- Lowest: $230.00 (Barclays)
- Average: $299.88
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$299.88 (+36.7%)
* Over Last 12-Mos
Rating Score: 6.9 / 10 Percentile Rank: 75%
Rating Score: 6.9 / 10 Percentile Rank: 75%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
2/14/2024 | Wells Fargo | Mohit Bansal | Downgrade | Equal Weight (Overweight) |
240.00 (315.00) |
226.65 (219.40) |
-3.2% | Details |
1/24/2024 | UBS » Updated 2/16/2024 |
Colin Bristow | Downgrade | Neutral (Buy) |
250.00 (276.00) |
251.68 (219.40) |
-12.83% | Details |